Pancreatic Cancer Research

ResearcherAsahikawa Medical UniversityNo recent work listed

Hiroaki Konishi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6477-721X; OpenAlex author ID A5101410383. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: 1 paper

Papers 3

  1. Mutant GNAS limits tumor aggressiveness in established pancreatic cancer via antagonizing the KRAS-pathway. Co-author DOI 10.1007/s00535-021-01846-4↗
  2. Probiotic Aspergillus oryzae produces anti-tumor mediator and exerts anti-tumor effects in pancreatic cancer through the p38 MAPK signaling pathway. Co-author DOI 10.1038/s41598-021-90707-4↗
  3. Probiotic‑derived ferrichrome inhibits the growth of refractory pancreatic cancer cells. Co-author DOI 10.3892/ijo.2020.5096↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mikihiro Fujiya · 3 shared papers, 2020–2022 · strength 0.33
  2. Toshikatsu Okumura · 2 shared papers, 2020–2022 · strength 0.21
  3. Tetsuhiro Okada · 1 shared paper, 2022 · strength 0.11
  4. Kenji Takahashi · 1 shared paper, 2022 · strength 0.11
  5. Hiroki Sato · 1 shared paper, 2022 · strength 0.11
  6. Hidemasa Kawabata · 1 shared paper, 2022 · strength 0.11
  7. Andrew Scott Liss · 1 shared paper, 2022 · strength 0.11
  8. Yusuke Mizukami · 1 shared paper, 2022 · strength 0.11
  9. Akemi Kita · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.